{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:06:08Z","timestamp":1792796768663,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T00:00:00Z","timestamp":1750550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T00:00:00Z","timestamp":1750550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the CAMS Innovation Fund for Medical Sciences","award":["CIFMS # 2022-I2M-1-001"],"award-info":[{"award-number":["CIFMS # 2022-I2M-1-001"]}]},{"name":"the CAMS Innovation Fund for Medical Sciences","award":["CIFMS #2021-I2M-1-025"],"award-info":[{"award-number":["CIFMS #2021-I2M-1-025"]}]},{"name":"the STI2030-Major Project","award":["2021ZD0201100 Task 1 #2021ZD0201101"],"award-info":[{"award-number":["2021ZD0201100 Task 1 #2021ZD0201101"]}]},{"name":"the State Key Laboratory Special Fund","award":["2060204"],"award-info":[{"award-number":["2060204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Alzheimer\u2019s disease (AD) is an age-related neurodegenerative disorder. Different types of A\u03b2 plaques are likely to play distinct roles in the brains of patients with AD. In this study, through the combination of pathological techniques and analysis of the human brain database, we discovered that focal A\u03b2 plaques (FAPs), rather than diffuse A\u03b2 plaques (DAPs), are significantly correlated with AD-related neuropathological changes and cognitive impairment. By using laser capture microdissection in conjunction with microproteomics, the protein components of different A\u03b2 plaques were characterized. Bioinformatic analysis indicated that FAP-enriched proteins are associated mainly with immune-related pathways, such as neutrophil extracellular trap formation. We further confirmed that myeloperoxidase (MPO) is significantly upregulated in the AD brain and colocalizes with FAPs but not with DAPs. Immunohistochemical staining demonstrated that neutrophils expressing MPO accumulated in the capillary lumen and brain parenchyma. The number of neutrophils significantly increases in the cortex and hippocampus of AD donors. Our study revealed a potential role for neutrophil-derived MPO in FAPs, providing insights into the pathogenesis mechanisms and potential therapeutic targets of AD.<\/jats:p>","DOI":"10.1186\/s13041-025-01226-6","type":"journal-article","created":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T10:38:42Z","timestamp":1750588722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Distinct composition of different types of Abeta plaques in the pathogenesis of Alzheimer\u2019s disease and the role of neutrophil-derived myeloperoxidase"],"prefix":"10.1186","volume":"18","author":[{"given":"Jianru","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-sha","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,22]]},"reference":[{"key":"1226_CR1","doi-asserted-by":"publisher","first-page":"101318","DOI":"10.1016\/j.arr.2021.101318","volume":"68","author":"M Stoiljkovic","year":"2021","unstructured":"Stoiljkovic M, Horvath TL, Haj\u00f3s M. Therapy for Alzheimer\u2019s disease: missing targets and functional markers? Ageing Res Rev. 2021;68:101318.","journal-title":"Ageing Res Rev"},{"key":"1226_CR2","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1517\/17460441.2014.930124","volume":"9","author":"R Cacabelos","year":"2014","unstructured":"Cacabelos R, Torrellas C. Epigenetic drug discovery for Alzheimer\u2019s disease. Expert Opin Drug Discov. 2014;9:1059\u201386.","journal-title":"Expert Opin Drug Discov"},{"key":"1226_CR3","doi-asserted-by":"publisher","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","volume":"2","author":"C Haass","year":"2012","unstructured":"Haass C, Kaether C, Thinakaran G, Sisodia S. Trafficking and proteolytic processing of APP. Cold Spring Harbor Perspect Med. 2012;2:a006270.","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"1226_CR4","doi-asserted-by":"publisher","first-page":"101496","DOI":"10.1016\/j.arr.2021.101496","volume":"72","author":"D Jeremic","year":"2021","unstructured":"Jeremic D, Jim\u00e9nez-D\u00edaz L, Navarro-L\u00f3pez JD. Past, present and future of therapeutic strategies against amyloid-\u03b2 peptides in Alzheimer\u2019s disease: a systematic review. Ageing Res Rev. 2021;72:101496.","journal-title":"Ageing Res Rev"},{"key":"1226_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM. Alzheimer\u2019s disease. N Engl J Med. 2010;362:329\u201344.","journal-title":"N Engl J Med"},{"key":"1226_CR6","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/nn.3806","volume":"17","author":"JA Elman","year":"2014","unstructured":"Elman JA, Oh H, Madison CM, et al. Neural compensation in older people with brain amyloid-\u03b2 deposition. Nat Neurosci. 2014;17:1316\u20138.","journal-title":"Nat Neurosci"},{"key":"1226_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0002-9440(10)63360-3","volume":"165","author":"T Bussi\u00e8re","year":"2004","unstructured":"Bussi\u00e8re T, Bard F, Barbour R, et al. Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance. Am J Pathol. 2004;165:987\u201395.","journal-title":"Am J Pathol"},{"key":"1226_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/10520290903389445","volume":"85","author":"MR D\u2019Andrea","year":"2010","unstructured":"D\u2019Andrea MR, Nagele RG. Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer\u2019s disease pathogenesis. Biotech Histochem. 2010;85:133\u201347.","journal-title":"Biotech Histochem"},{"key":"1226_CR9","doi-asserted-by":"crossref","unstructured":"Dickson TC, Vickers JC. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer\u2019s disease. Neuroscience. 2001;105.","DOI":"10.1016\/S0306-4522(01)00169-5"},{"key":"1226_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00401-010-0679-9","volume":"119","author":"GK Gouras","year":"2010","unstructured":"Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E. Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer\u2019s disease. Acta Neuropathol. 2010;119:523\u201341.","journal-title":"Acta Neuropathol"},{"key":"1226_CR11","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1523\/JNEUROSCI.5167-03.2004","volume":"24","author":"RH Takahashi","year":"2004","unstructured":"Takahashi RH, Almeida CG, Kearney PF, et al. Oligomerization of Alzheimer\u2019s beta-amyloid within processes and synapses of cultured neurons and brain. J NeuroSci. 2004;24:3592\u20139.","journal-title":"J NeuroSci"},{"key":"1226_CR12","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s12264-022-00927-5","volume":"38","author":"F Liu","year":"2022","unstructured":"Liu F, Sun J, Wang X, et al. Focal-type, but not diffuse-type, amyloid beta plaques are correlated with Alzheimer\u2019s neuropathology, cognitive dysfunction, and neuroinflammation in the human hippocampus. Neurosci Bull. 2022;38:1125\u201338.","journal-title":"Neurosci Bull"},{"key":"1226_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jalz.2018.10.006","volume":"15","author":"F Xiong","year":"2019","unstructured":"Xiong F, Ge W, Ma C. Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer\u2019s disease. Alzheimer\u2019s Dement: J Alzheimer\u2019s Association. 2019;15:429\u201340.","journal-title":"Alzheimer\u2019s Dement: J Alzheimer\u2019s Association"},{"key":"1226_CR14","doi-asserted-by":"crossref","unstructured":"Mrdjen D, Pavlovic A, Hartmann FJ et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity. 2018;48.","DOI":"10.1016\/j.immuni.2018.02.014"},{"key":"1226_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25:270\u20136.","journal-title":"Nat Med"},{"key":"1226_CR16","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1084\/jem.20171406","volume":"214","author":"A Montagne","year":"2017","unstructured":"Montagne A, Zhao Z, Zlokovic BV. Alzheimer\u2019s disease: a matter of blood-brain barrier dysfunction? J Exp Med. 2017;214:3151\u201369.","journal-title":"J Exp Med"},{"key":"1226_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate D, Saligrama N, Leventhal O, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature. 2020;577:399\u2013404.","journal-title":"Nature"},{"key":"1226_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40478-022-01347-2","volume":"10","author":"LCD Smyth","year":"2022","unstructured":"Smyth LCD, Murray HC, Hill M, et al. Neutrophil-vascular interactions drive myeloperoxidase accumulation in the brain in Alzheimer\u2019s disease. Acta Neuropathol Commun. 2022;10:38.","journal-title":"Acta Neuropathol Commun"},{"key":"1226_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41593-018-0329-4","volume":"22","author":"JC Cruz Hern\u00e1ndez","year":"2019","unstructured":"Cruz Hern\u00e1ndez JC, Bracko O, Kersbergen CJ, et al. Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer\u2019s disease mouse models. Nat Neurosci. 2019;22:413\u201320.","journal-title":"Nat Neurosci"},{"key":"1226_CR20","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.3913","volume":"21","author":"E Zenaro","year":"2015","unstructured":"Zenaro E, Pietronigro E, Della Bianca V, et al. Neutrophils promote Alzheimer\u2019s disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med. 2015;21:880\u20136.","journal-title":"Nat Med"},{"key":"1226_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12264-018-0306-7","volume":"35","author":"W Qiu","year":"2019","unstructured":"Qiu W, Zhang H, Bao A, et al. Standardized operational protocol for human brain banking in China. Neurosci Bull. 2019;35:270\u20136.","journal-title":"Neurosci Bull"},{"key":"1226_CR22","doi-asserted-by":"crossref","unstructured":"Montine TJ, Phelps CH, Beach TG et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol. 2012;123.","DOI":"10.1007\/s00401-011-0910-3"},{"key":"1226_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1212\/WNL.0000000000006745","volume":"92","author":"Y Hara","year":"2019","unstructured":"Hara Y, McKeehan N, Fillit HM. Translating the biology of aging into novel therapeutics for Alzheimer disease. Neurology. 2019;92:84\u201393.","journal-title":"Neurology"},{"key":"1226_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/BF00294646","volume":"80","author":"T Suenaga","year":"1990","unstructured":"Suenaga T, Hirano A, Llena JF, Yen SH, Dickson DW. Modified Bielschowsky stain and immunohistochemical studies on striatal plaques in Alzheimer\u2019s disease. Acta Neuropathol. 1990;80:280\u20136.","journal-title":"Acta Neuropathol"},{"key":"1226_CR25","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1017\/S1355617712001609","volume":"19","author":"ST Farias","year":"2013","unstructured":"Farias ST, Park LQ, Harvey DJ, et al. Everyday cognition in older adults: associations with neuropsychological performance and structural brain imaging. J Int Neuropsychol Soc. 2013;19:430\u201341.","journal-title":"J Int Neuropsychol Soc"},{"key":"1226_CR26","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2174\/1567205011666141001120903","volume":"11","author":"GA Marshall","year":"2014","unstructured":"Marshall GA, Zoller AS, Kelly KE, et al. Everyday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairment. Curr Alzheimer Res. 2014;11:853\u201361.","journal-title":"Curr Alzheimer Res"},{"key":"1226_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jneuroim.2017.04.007","volume":"309","author":"DAE Hendrickx","year":"2017","unstructured":"Hendrickx DAE, van Eden CG, Schuurman KG, Hamann J, Huitinga I. Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology. J Neuroimmunol. 2017;309:12\u201322.","journal-title":"J Neuroimmunol"},{"key":"1226_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3233\/JAD-150217","volume":"47","author":"S Busse","year":"2015","unstructured":"Busse S, Steiner J, Alter J, et al. Expression of HLA-DR, CD80, and CD86 in healthy aging and Alzheimer\u2019s disease. J Alzheimers Dis. 2015;47:177\u201384.","journal-title":"J Alzheimers Dis"},{"key":"1226_CR29","doi-asserted-by":"publisher","first-page":"e2302720120","DOI":"10.1073\/pnas.2302720120","volume":"120","author":"Y Le Guen","year":"2023","unstructured":"Le Guen Y, Luo G, Ambati A, et al. Multiancestry analysis of the HLA locus in Alzheimer\u2019s and parkinson\u2019s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes. Proc Natl Acad Sci USA. 2023;120:e2302720120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1226_CR30","doi-asserted-by":"publisher","first-page":"105868","DOI":"10.1016\/j.neubiorev.2024.105868","volume":"165","author":"T-Q Ge","year":"2024","unstructured":"Ge T-Q, Guan P-P, Wang P. Complement 3a induces the synapse loss via C3aR in mitochondria-dependent NLRP3 activating mechanisms during the development and progression of Alzheimer\u2019s disease. Neurosci Biobehav Rev. 2024;165:105868.","journal-title":"Neurosci Biobehav Rev"},{"key":"1226_CR31","doi-asserted-by":"crossref","unstructured":"Shi Q, Chowdhury S, Ma R et al. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice. Sci Transl Med. 2017;9.","DOI":"10.1126\/scitranslmed.aaf6295"},{"key":"1226_CR32","doi-asserted-by":"crossref","unstructured":"Fu H, Liu B, Frost JL et al. Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar A\u03b2 by microglia. Glia. 2012;60.","DOI":"10.1002\/glia.22331"},{"key":"1226_CR33","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/0091-6749(86)90404-5","volume":"77","author":"J Falloon","year":"1986","unstructured":"Falloon J, Gallin JI. Neutrophil granules in health and disease. J Allergy Clin Immunol. 1986;77:653\u201362.","journal-title":"J Allergy Clin Immunol"},{"key":"1226_CR34","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3024","volume":"11","author":"A Mantovani","year":"2011","unstructured":"Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011;11:519\u201331.","journal-title":"Nat Rev Immunol"},{"key":"1226_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41588-020-00773-z","volume":"53","author":"AP Wingo","year":"2021","unstructured":"Wingo AP, Liu Y, Gerasimov ES, et al. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer\u2019s disease pathogenesis. Nat Genet. 2021;53:143\u20136.","journal-title":"Nat Genet"},{"key":"1226_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-021-00474-z","volume":"16","author":"B Bai","year":"2021","unstructured":"Bai B, Vanderwall D, Li Y, et al. Proteomic landscape of Alzheimer\u2019s disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegeneration. 2021;16:55.","journal-title":"Mol Neurodegeneration"},{"key":"1226_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","volume":"25","author":"ECB Johnson","year":"2022","unstructured":"Johnson ECB, Carter EK, Dammer EB, et al. Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat Neurosci. 2022;25:213\u201325.","journal-title":"Nat Neurosci"},{"key":"1226_CR38","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.neuron.2020.04.031","volume":"106","author":"B Bai","year":"2020","unstructured":"Bai B, Wang X, Li Y, et al. Deep multilayer brain proteomics identifies molecular networks in Alzheimer\u2019s disease progression. Neuron. 2020;106:700.","journal-title":"Neuron"},{"key":"1226_CR39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s43587-022-00281-1","volume":"2","author":"B Dejanovic","year":"2022","unstructured":"Dejanovic B, Wu T, Tsai M-C, et al. Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer\u2019s disease mouse models. Nat Aging. 2022;2:837\u201350.","journal-title":"Nat Aging"},{"key":"1226_CR40","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Sci (New York NY). 2016;352:712\u20136.","journal-title":"Sci (New York NY)"},{"key":"1226_CR41","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1042\/CS20230513","volume":"138","author":"J Nimmo","year":"2024","unstructured":"Nimmo J, Byrne RAJ, Daskoulidou N, et al. The complement system in neurodegenerative diseases. Clin Sci (Lond). 2024;138:387\u2013412.","journal-title":"Clin Sci (Lond)"},{"key":"1226_CR42","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3233\/JAD-220642","volume":"89","author":"JR Wright","year":"2022","unstructured":"Wright JR, Deen QFE, Stevenson A, et al. Plasma myeloperoxidase as a potential biomarker of patient response to anti-dementia treatment in Alzheimer\u2019s disease. J Alzheimers Dis. 2022;89:1483\u201392.","journal-title":"J Alzheimers Dis"},{"key":"1226_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3233\/JAD-131469","volume":"39","author":"S Tzikas","year":"2014","unstructured":"Tzikas S, Schlak D, Sopova K, et al. Increased myeloperoxidase plasma levels in patients with Alzheimer\u2019s disease. J Alzheimers Dis. 2014;39:557\u201364.","journal-title":"J Alzheimers Dis"},{"key":"1226_CR44","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00441-017-2626-8","volume":"369","author":"S Gellhaar","year":"2017","unstructured":"Gellhaar S, Sunnemark D, Eriksson H, Olson L, Galter D. Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in parkinson\u2019s and Alzheimer\u2019s disease. Cell Tissue Res. 2017;369:445\u201354.","journal-title":"Cell Tissue Res"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-025-01226-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-025-01226-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-025-01226-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T10:38:44Z","timestamp":1750588724000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-025-01226-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1226"],"URL":"https:\/\/doi.org\/10.1186\/s13041-025-01226-6","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,22]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies were approved by the Ethics Committee of the Institute of Basic Medical Sciences Chinese Academy of Medical Sciences (Approval Numbers: 009\u20132014, 031\u20132017, and 2022125).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}